Analytical Tool - Prostate Cancer

BioSeeker Group AB
March 25, 2014
SKU: BIOS5221725
Metastatic Nonseminomatous Testicular Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Metastatic Nonseminomatous Testicular Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Metastatic Nonseminomatous Testicular Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs  |  read more...
USD 2,000
Metastatic Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Metastatic Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Metastatic Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed  |  read more...
USD 2,000
Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across  |  read more...
USD 2,000
Small-Cell Lung Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Small-Cell Lung Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Small-Cell Lung Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed  |  read more...
USD 2,000
Soft Tissue Sarcoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Soft Tissue Sarcoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Soft Tissue Sarcoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed  |  read more...
USD 2,000
Refractory Multiple Myeloma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Refractory Multiple Myeloma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Refractory Multiple Myeloma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed  |  read more...
USD 2,000
Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across  |  read more...
USD 2,000
Bone Sarcoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Bone Sarcoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Bone Sarcoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across  |  read more...
USD 2,000
Cystic Fibrosis Market in Europe 2015-2019
2/18/2015 | published by: TechNavio - Infiniti Research Ltd.
Cystic Fibrosis Market in Europe 2015-2019 About Cystic Fibrosis Cystic fibrosis, also known as mucoviscidosis, is a genetically inherited disease. The primary symptoms of cystic fibrosis include high salt content in the sweat, breathing difficulties, secretion of  |  read more...
USD 3,000
Global Infertility Market 2015-2019
2/18/2015 | published by: TechNavio - Infiniti Research Ltd.
Global Infertility Market 2015-2019 About Infertility Infertility is a widespread problem, and it is the inability to conceive after having regular unprotected sex. In one-third of the cases, infertility is because of either female infertility factors or  |  read more...
USD 2,500
 

SELECT A LICENSE

    Electronic Access
Global Site License Fulfilled by Publisher
  USD 11,625  
    Electronic Access
Single User Fulfilled by Publisher
  USD 4,650  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!